Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,733.50
Bid: 1,732.50
Ask: 1,733.00
Change: 5.00 (0.29%)
Spread: 0.50 (0.029%)
Open: 1,733.00
High: 1,739.50
Low: 1,724.50
Prev. Close: 1,728.50
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

LIVE MARKETS-Late morning single stock market price action burst

Tue, 12th Oct 2021 12:05

* European shares pare losses

* Wall Street futures tick up

* China's Evergrande continues to weigh

Oct 12 - Welcome to the home for real-time coverage of
markets brought to you by Reuters reporters. You can share your
thoughts with us at markets.research@thomsonreuters.com

LATE MORNING SINGLE STOCK MARKET PRICE ACTION BURST (1043
GMT)

The STOXX 600 is gradually erasing most of its early losses
and making its way close to the flotation mark.

But while a -0.02% move doesn't qualify for an exciting
session for the benchmark, this doesn't mean it has been
uneventful underneath the surface.

About just an hour ago, there were pretty big and sudden
moves in London and Helsinki.

Shares in GSK jumped after Bloomberg reported private equity
firms' interest for the group's $54 billion consumer arm.

At roughly the same time, Stora Enso and
UPM-Kymmene Corporation both dropped after EU antitrust
regulators said they raided wood pulp makers in several
countries as part of a cartel investigation.

UPM just confirmed EU competition authorities were
conducting an unannounced inspection at its premises while there
were no immediate announcement from Stora Enso.

Here's what the sudden market price action looked like
(Helsinki is two hours ahead London):

(Julien Ponthus)

*****

EARNINGS SEASON FLAVOUR: VALUE! (0927 GMT)

Again? Yes again!

Calls for investors to look for value (otherwise known as
cheap) stocks have been risen seemingly as fast as German bund
and U.S Treasury yields lately.

Sell-side and buy-side analysts have been flagging that
these areas of the stock markets are typically winners when
inflation kicks in and with the earnings season opening, these
calls continue to pour in.

There's already been a few episodes of investors quickly
rotating their portfolio from growth and tech to value,
particularly last year when the COVID-19 vaccine breakthroughs
were announced in November.

According to Amundi, there's now another investing window
open across U.S. equities.

"In our view, investors will have a second chance to exploit
opportunities in the value space", wrote U.S. portfolio managers
Marco Pirondini and Alec Murray.

Stocks in the energy and financial spaces "should benefit
from higher inflation, the upward trend for commodity prices,
and a rising interest rate environment", they argue.

While tech was the ultimate winner during the first phase of
the pandemic, "higher interest rates mean a higher discount
rate, which lowers the net present value of future cash flows
for those growth names", they add.

One other argument is that "value trades at its steepest
discount to growth since 1999".

See the Amundi chart below:

(Julien Ponthus)

*****

EUROPEAN STOCKS SLIP INTO RISK-OFF (0810 GMT)

European shares slipped into risk-off mode as the energy
price crisis continued to hit sentiment ahead of the corporate
earnings season.

The pan European index STOXX 600 is down 0.6%, with
economically sensitive mining, autos and banking
sectors leading the losses, shedding more than 1%.

All the main regional indexes are also trading in negative
territory.

Declines in heavyweight mining stocks are pushing the FTSE
down 0.7% as higher energy costs, supply chain disruptions and
an imminent rate hike weigh.

Fuelling inflation fears, data showed that British employers
took their payrolls to a record high in September, while average
weekly earnings were 7.2% higher than in the same three months
of 2020, but slowing from the previous reading of 8.3%.

(Joice Alves)

*****

THE WAITING GAME (0705 GMT)

So many question marks these days: will the inflation spike
we are witnessing ebb? Will central banks resist temptation to
significantly tighten policy? How much of a dampener is $80 oil
for the world economy? Are China's property sector problems a
sign of a wider malaise?

These narratives have kept world stocks seesawing ever since
they hit record highs in early-September. Wall Street futures
are down half a percent while European shares look set for an
even weaker open. Big losses in Asia earlier, with Hong Kong
down more than 1%.

On bonds, softer growth data is failing to derail a selloff;
10-year Treasury yields are up some 30 basis points in three
weeks and on Tuesday, two-year yields touched 18-month highs.

The impact of soaring energy prices is showing up in
dataprints -- even in Japan, wholesale inflation hit a 13-year
high. British shoppers, meanwhile, upped spending by just 0.6%
in September versus 3% in August (though fuel shortages peculiar
to the UK probably had an outsize impact).

Another worrying piece of data is last month's 20% slump in
Chinese car sales, which will likely ripple out to global auto
shares. The Chinese slowdown could also make itself
felt in Germany's ZEW index later in the day.

On the bright side, UK payrolls hit a record high in
September, with a 7.2% rise in average weekly earnings in the
three months to August.

All that comes just before third quarter earnings kick off.
Remember several companies have already issued downbeat
assessments of how higher prices will have impacted the bottom
line. Q3 earnings were never expected to match the Q2 blowout
but will they fall short even of the 30% growth expected of U.S.
companies? The wait is on.

Key developments that should provide more direction to
markets on Tuesday:
-China's Evergrande missed a third round of bond payments
-Japan wholesale inflation at 13-year high in September
- UK retail spending rose 0.6% in Sept vs 3% increase
.
- IMF issues its updated World Economic Outlook
- ECB’s Chair of the Supervisory Board, Andrea Enria, board
members Philip Lane, Frank Elderson,
- Bank of Korea holds rates, flags November hike
- German ZEW
- U.S. JOLTS job openings
- U.S. Treasury auctions $96 billion in 3-year and 10-year notes

(Sujata Rao)

*****

EUROPEAN STOCK FUTURES DIP AROUND 1% (0630 GMT)

Futures are pointing to a start of the day in negative
territory for European bourses amid a global energy crunch,
clouding sentiment before the U.S. corporate earnings season.

Futures on main regional benchmarks are down around 1%,
after oil prices jumped on Monday to the highest levels in
years, fuelling inflation fears.

Also weighing on investor sentiment, Reuters reported that
some of China Evergrande Group's offshore bondholders have not
received interest payment by a Monday deadline.

(Joice Alves)

*****

More News
22 Nov 2023 09:48

LONDON BROKER RATINGS: RBC cuts HSBC; Liberum cuts Glencore

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and Tuesday:

Read more
21 Nov 2023 11:52

GSK to begin phase 3 trials of low-carbon Ventolin inhaler in 2024

(Alliance News) - GSK PLC on Tuesday said it will begin phase 3 trials of a low carbon version of its metered dose inhaler Ventolin using a "next generation" propellant in 2024.

Read more
14 Nov 2023 17:04

LONDON MARKET CLOSE: FTSE 100 underwhelms as stocks jump after US CPI

(Alliance News) - European equities jumped in the wake of a cooler-than-expected US inflation reading, which took some sting out of a recent hawkish reassessment of the Federal Reserve interest rate outlook.

Read more
13 Nov 2023 09:47

GSK hails momelotinib opinion from European Medicines Agency committee

(Alliance News) - GSK PLC on Monday announced that a European Medicines Agency panel has given a positive opinion recommending momelotinib to treat myelofibrosis patients with anaemia.

Read more
9 Nov 2023 15:50

UK dividends calendar - next 7 days

Friday 10 November 
Bodycote PLCdividend payment date
Breedon Group PLCdividend payment date
Chesnara PLCdividend payment date
Finsbury Growth & Income Trust PLCdividend payment date
Invesco Bond Income Plus Ltddividend payment date
JPMorgan Emerging Markets Investment Trust PLCdividend payment date
Kerry Group PLCdividend payment date
Merchants Trust PLCdividend payment date
Mid Wynd International Investment Trust PLCdividend payment date
Mid Wynd International Investment Trust PLCspecial dividend payment date
Montanaro UK Smaller Cos Investment Trust PLCdividend payment date
Senior PLCdividend payment date
Spectris PLCdividend payment date
Spirax-Sarco Engineering PLCdividend payment date
Travis Perkins PLCdividend payment date
Monday 13 November 
no events scheduled 
Tuesday 14 November 
no events scheduled 
Wednesday 15 November 
Coats Group PLCdividend payment date
Ferguson PLCdividend payment date
JP Morgan Mid Cap Investment Trust PLCdividend payment date
Strategic Equity Capital PLCdividend payment date
Thursday 16 November 
abrdn Property Income Trust Ltdex-dividend payment date
Asian Energy Impact Trust PLCex-dividend payment date
Baillie Gifford Japan Trust PLCex-dividend payment date
BlackRock Greater Europe Investment Trust PLCex-dividend payment date
Bunzl PLCex-dividend payment date
Bytes Technology Group PLCex-dividend payment date
Centrica PLCdividend payment date
Coca-Cola Europacific Partners PLCex-dividend payment date
DX Group PLCex-dividend payment date
Empiric Student Property PLCex-dividend payment date
Fonix Mobile PLCex-dividend payment date
GCP Asset Backed Income Fund Ltdex-dividend payment date
GSK PLCex-dividend payment date
Hargreaves Lansdown PLCex-dividend payment date
Henderson Opportunities Trust PLCex-dividend payment date
ICG Enterprise Trust PLCex-dividend payment date
James Halstead PLCex-dividend payment date
Lancashire Holdings Ltdspecial ex-dividend payment date
Majedie Investments PLCex-dividend payment date
Marks & Spencer Group PLCex-dividend payment date
Murray Income Trust PLCex-dividend payment date
New Star Investment Trust PLCex-dividend payment date
NextEnergy Solar Fund Ltdex-dividend payment date
Octopus Renewables Infrastructure Trust PLCex-dividend payment date
Pershing Square Holdings Ltdex-dividend payment date
Personal Group Holdings PLCdividend payment date
Redrow PLCdividend payment date
Regional REIT Ltdex-dividend payment date
Schroder Oriental Income Fund Ltdex-dividend payment date
Scottish American Investment Co PLCex-dividend payment date
SCS Group PLCex-dividend payment date
Shell PLCex-dividend payment date
Supermarket Income REIT PLCdividend payment date
UK Commercial Property REIT Ltdex-dividend payment date
Unilever PLCex-dividend payment date
Wincanton PLCex-dividend payment date
  
Copyright 2023 Alliance News Ltd. All Rights Reserved.

Read more
8 Nov 2023 09:30

LONDON BROKER RATINGS: UBS downbeat on AJ Bell and Hargreaves Lansdown

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and Tuesday:

Read more
2 Nov 2023 10:14

LONDON BROKER RATINGS: Bank of America starts Unite Group with 'buy'

(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning and Wednesday:

Read more
1 Nov 2023 16:52

LONDON MARKET CLOSE: Stocks prosper ahead of central bank rate calls

(Alliance News) - Stocks in London took their lead from a positive start on Wall Street to close higher as investors prepare for interest rate decisions in the UK and US.

Read more
1 Nov 2023 16:35

London close: Stocks rise ahead of US Fed policy decision

(Sharecast News) - London's stock market finished in positive territory on Wednesday, with investors keeping a keen eye on the upcoming policy announcement from the US Federal Reserve.

Read more
1 Nov 2023 08:51

TOP NEWS: GSK ups guidance as boosted by Shingrix and Arexvy

(Alliance News) - GSK PLC on Wednesday hailed the performance of the world's first approved respiratory syncytial virus vaccine Arexvy, as it reported a rise in profit and revenue.

Read more
1 Nov 2023 08:50

LONDON MARKET OPEN: FTSE 100 up, FTSE 250 down as Aston Martin tumbles

(Alliance News) - Stock prices in London opened mixed on Wednesday, ahead of key central bank decisions, as investors were cheered by some strong updates from large-cap listings.

Read more
1 Nov 2023 07:40

LONDON BRIEFING: GSK raises annual guidance following Arexvy launch

(Alliance News) - Stocks in London are called higher on Wednesday, with the main focal point for the day being the upcoming US interest rate decision.

Read more
1 Nov 2023 07:27

GSK hikes guidance after strong third quarter

(Sharecast News) - GSK announced a robust third quarter on Wednesday, prompting an upgrade to its full-year guidance.

Read more
30 Oct 2023 09:01

IN BRIEF: GSK says Jemperli meets endpoint in endometrial cancer trial

GSK PLC - Brentford, west London-based pharmaceutical maker - Jemperli, whose generic name is dostarlimab, meets endpoint of overall survival in phase III Ruby trial on adult patients with primary advanced or recurrent endometrial cancer. Jemperli, combined with standard-of-care chemotherapy, followed by dostarlimab, demonstrated a "statistically significant and clinically meaningful benefit" to the patients in the trial.

Read more
30 Oct 2023 07:06

GSK's Jemperli sees success in endometrial cancer trial

(Sharecast News) - GSK reported encouraging outcomes from part one of the 'RUBY' phase three trial evaluating the efficacy of 'Jemperli', or dostarlimab, with standard chemotherapy for treating adult patients with advanced or recurrent endometrial cancer on Monday.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.